- Home
- TMDE vs MRSN Comparison
TMDE vs MRSN Comparison
Compare TMDE & MRSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TMDE
- MRSN
- Stock Information
- Founded
- TMDE 2016
- MRSN 2001
- Country
- TMDE Malaysia
- MRSN United States
- Employees
- TMDE N/A
- MRSN N/A
- Industry
- TMDE Oil Refining/Marketing
- MRSN Biotechnology: Pharmaceutical Preparations
- Sector
- TMDE Energy
- MRSN Health Care
- Exchange
- TMDE Nasdaq
- MRSN Nasdaq
- Market Cap
- TMDE 30.9M
- MRSN 37.0M
- IPO Year
- TMDE 2025
- MRSN 2017
- Fundamental
- Price
- TMDE $0.85
- MRSN $7.41
- Analyst Decision
- TMDE
- MRSN Strong Buy
- Analyst Count
- TMDE 0
- MRSN 4
- Target Price
- TMDE N/A
- MRSN $63.67
- AVG Volume (30 Days)
- TMDE 68.2K
- MRSN 137.0K
- Earning Date
- TMDE 05-14-2025
- MRSN 08-13-2025
- Dividend Yield
- TMDE N/A
- MRSN N/A
- EPS Growth
- TMDE N/A
- MRSN N/A
- EPS
- TMDE 0.09
- MRSN N/A
- Revenue
- TMDE $688,607,542.00
- MRSN $34,769,000.00
- Revenue This Year
- TMDE N/A
- MRSN N/A
- Revenue Next Year
- TMDE N/A
- MRSN $1.03
- P/E Ratio
- TMDE $9.41
- MRSN N/A
- Revenue Growth
- TMDE 8.77
- MRSN 16.14
- 52 Week Low
- TMDE $0.67
- MRSN $5.21
- 52 Week High
- TMDE $6.27
- MRSN $70.75
- Technical
- Relative Strength Index (RSI)
- TMDE N/A
- MRSN 48.25
- Support Level
- TMDE N/A
- MRSN $5.21
- Resistance Level
- TMDE N/A
- MRSN $7.72
- Average True Range (ATR)
- TMDE 0.00
- MRSN 0.53
- MACD
- TMDE 0.00
- MRSN 0.07
- Stochastic Oscillator
- TMDE 0.00
- MRSN 77.84
About TMDE TMD Energy Limited Ordinary Shares
TMD Energy Ltd is engaged in marine fuel bunkering services specializing in the supply and marketing of marine gas oil and marine fuel oil (including high sulfur fuel oil, low sulfur fuel oil and very low sulfur fuel oil), to ships and vessels at sea. It is also involved in the provision of ship management services for in-house and external vessels, as well as vessel chartering. It is currently operating with a fleet of nearly 15 bunkering vessels ranging from 540 dwt to 7,820 dwt, of which nearly nine (9) are double bottom and double hull vessels with an average cargo-carrying capacity of approximately 4,200 dwt each.
About MRSN Mersana Therapeutics Inc.
Mersana Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing antibody-drug conjugates (ADCs) that offer a clinically meaningful benefit for cancer patients with unmet needs. The Company's next-generation ADC platforms include Dolasynthen, which delivers a proprietary auristatin payload, and Immunosynthen, which delivers a proprietary stimulator of interferon genes (STING) agonist payload. Its pipeline includes Emi-Le (XMT-1660), XMT-2056, XMT-2068, and XMT-2175.